News Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Market Closed - Nyse Other stock markets 04:00:02 2024-04-15 pm EDT			5-day change	1st Jan Change
16.29 ^USD	-1.75%		-4.01%	-14.71%

Mar. 12	Transcript : Arcus Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM
Feb. 29	Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arcus Biosciences Announces New Employment Inducement Grants	Apr. 09	BU
Arcus Biosciences Announces New Employment Inducement Grants	Mar. 26	BU
Transcript : Arcus Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM	Mar. 12
Arcus Biosciences Announces New Employment Inducement Grants	Mar. 11	BU
Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	Feb. 29	MT
Arcus Biosciences Insider Sold Shares Worth $543,187, According to a Recent SEC Filing	Feb. 29	MT
Arcus Biosciences to Participate in Two Upcoming Investor Conferences	Feb. 28	BU
Arcus Biosciences Announces New Employment Inducement Grants	Feb. 27	BU
Transcript : Arcus Biosciences, Inc. Presents at Citi 2024 Virtual Oncology Leadership Summit, Feb-22-2024 11:00 AM	Feb. 22
Transcript : Arcus Biosciences, Inc., Q4 2023 Earnings Call, Feb 21, 2024	Feb. 21
Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q4 Revenue $31M	Feb. 21	MT
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update	Feb. 21	BU
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Arcus Biosciences Announces New Employment Inducement Grants	Feb. 09	BU
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates	Feb. 07	BU
Gilead and Arcus Announce Amended Collaboration Agreement	Jan. 31	CI
Global markets live: WPP UPS GM, Super Micro Computer, Microsoft...	Jan. 30
Mizuho Adjusts Arcus Biosciences' Price Target to $42 From $51, Keeps Buy Rating	Jan. 30	MT
Wedbush Lowers Arcus Biosciences' PT to $30 From $36 After Announced Plans to Discontinue Enrollment for Phase 3 ARC-10 Study; Keeps Outperform Rating	Jan. 30	MT
North American Morning Briefing : Microsoft Kicks Off Big Tech Bonanza	Jan. 30	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Summary

Filters